 |
|
Intravenous Tenecteplase for Acute Ischemic Stroke Within 4.5–24 Hours of Onset (ROSE-TNK): A Phase 2, Randomized, Multicenter Study
Lu Wang, Ying-Jie Dai, Yu Cui, Hong Zhang, Chang-Hao Jiang, Ying-Jie Duan, Yong Zhao, Ye-Fang Feng, Shi-Mei Geng, Zai-Hui Zhang, Jiang Lu, Ping Zhang, Li-Wei Zhao, Hang Zhao, Yu-Tong Ma, Cheng-Guang Song, Yi Zhang, Hui-Sheng Chen
J Stroke. 2023;25(3):371-377. Published online 2023 Aug 24 DOI: https://doi.org/10.5853/jos.2023.00668
|
|
Citations to this article as recorded by
 Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis
Lina Palaiodimou, Aristeidis H. Katsanos, Guillaume Turc, Michele Romoli, Aikaterini Theodorou, Robin Lemmens, Simona Sacco, Georgios Velonakis, Charalambos Vlachopoulos, Georgios Tsivgoulis
Therapeutic Advances in Neurological Disorders.2024;[Epub] CrossRef
|